Are Unique Regional Factors the Missing Link in India’s COVID-19-Associated Mucormycosis Crisis?-Reference-Cited by-同舟云学术

Are Unique Regional Factors the Missing Link in India’s COVID-19-Associated Mucormycosis Crisis?

Published:2022-04-26 Issue:2 Volume:13 Page:
ISSN:2150-7511
Container-title:mBio
language:en
Short-container-title:mBio

Author:

Skaria Jessy¹,John Teny M.²^ORCID,Varkey Shibu³,Kontoyiannis Dimitrios P.²^ORCID

Affiliation:

1. Independent Researcher, Houston, Texas, USA

2. Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

3. Maxivision Eye Hospitals, Trichy, Tamil Nadu, India

Abstract

The exact cause of the disproportionate increase in COVID-19-associated mucormycosis (CAM) cases in India remains unknown. Most researchers consider the major cause of India’s CAM epidemic to be the conjunction of the COVID-19 pandemic and associated corticosteroid treatment with the enormous number of Indians with diabetes mellitus (DM). However, excess CAM cases were not seen to the same extent in the Western world, where diabetes is prevalent and corticosteroids are also used extensively for COVID-19 treatment.

Publisher

American Society for Microbiology

Subject

Virology,Microbiology

Link

https://journals.asm.org/doi/pdf/10.1128/mbio.00473-22

Reference56 articles.

1. Global Epidemiology of Mucormycosis

2. COVID-19-associated mucormycosis: an epidemic within a pandemic

3. Hagen A. 2021. COVID-19-associated mucormycosis: triple threat of the pandemic. American Society for Microbiology Washington DC. https://asm.org/Articles/2021/July/COVID-19-Associated-Mucormycosis-Triple-Threat-of. Accessed 24 November 2021.

4. The recent mucormycosis storm over Indian sky

5. Results from a national survey on COVID‐19‐associated mucormycosis in Germany: 13 patients from six tertiary hospitals

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of COVID with Mycosis in General;Infectious Disorders - Drug Targets;2024-09

2. Multiple roles for hypoxia inducible factor 1-alpha in airway epithelial cells during mucormycosis;Nature Communications;2024-06-20

3. The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research;Journal of Fungi;2024-05-27

4. Pathogenesis of COVID-19-Associated Mucormycosis: An Updated Evidence-Based Review;Current Fungal Infection Reports;2024-02-01

5. Re: “COVID-19, mucormycosis, and the cow: Damned lies!”;Indian Journal of Medical Microbiology;2023-11